AWareness of Chemsex Among pRofEssionals iN gErman Speaking countrieS
Not yet recruiting
- Conditions
- F19.2sexualised substance use, chemsex
- Registration Number
- DRKS00028563
- Lead Sponsor
- Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Bezirkskliniken Schwaben, BKH Augsburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
Physicians of various specialities
Exclusion Criteria
None
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method In the context of this study, we will investigate (i) the extent to which practitioners from different disciplines are aware of the phenomenon of chemsex and its background, (ii) the extent to which certain socio-demographic data correlate with awareness of the topic, and (iii) the extent to which stigmatisation by practitioners influences their awareness.
- Secondary Outcome Measures
Name Time Method - Correlation of socio-demographic data and SABA scale<br>- Correlation of SABA scale and medical specialty<br>- Correlation of medical specialty and SABA scale
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie chemsex-related substance use in F19.2 disorder populations?
How does chemsex awareness among healthcare professionals impact treatment outcomes in German-speaking countries?
Are there specific biomarkers that correlate with sexualised substance use patterns in clinical settings?
What adverse events are commonly associated with chemsex practices and how can they be effectively managed?
What combination therapies or alternative approaches show promise in addressing chemsex behaviors compared to standard interventions?